No Data
Jefferies Adjusts Sumitomo Pharma's Price Target to 1,100 Yen From 900 Yen, Keeps at Buy
Sumitomo Pharma Extends Executive Pay Cuts Amid Financial Challenges
Sumitomo Pharma: Extraordinary Report
The Nikkei average fell by 1,052 yen, with concerns about performance due to U.S. mutual tariffs, over 90% of Main Board stocks decreased = three days ago.
Three days ago, the Nikkei average stock price fell sharply to 34,673.69 yen, down 1,052.18 yen from the previous day, marking a decline for the first time in three days. The TOPIX (Tokyo Stock Price Index) also significantly dropped by 87.58 points to 2,562.71 points. On the 2nd, U.S. President Trump announced the details of reciprocal tariffs, stating that a 24% tax would be imposed on Japan. Japanese stocks were pressured by concerns over the performance of export-related companies, and there was selling pressure due to the decline in U.S. stock index futures in Extended hours trading. The Nikkei average was at 9:02 AM.
List of cloud breakout stocks (Part 2) [Ichimoku Kinko Hyo - List of cloud breakout stocks]
○ List of stocks falling below the clouds in the market Code Stock Name Closing Price Leading Span A Leading Span B Tokyo Main Board <1301> Kyokuyo 4155 4176.25 4170 <1762> Takamatsu G 2736 2750 2738.5 <1803> Shimizu Construction 1323 1393.5 1334 <1885> Toa Construction 1287 1343 1298 <1926> Wright Works 2413 2526.5 2425 <1959> Ku
Sumitomo Pharma - Significant decline, announced the transfer of its Pharmaceutical Business in Asia.
Significant continued decline. It has been announced that the Retail Drug business in Asia will be transferred to Marubeni. They sell about 50 pharmaceuticals primarily focused on infectious diseases and central nervous system drugs in China and Southeast Asia, with the Asia business revenue for the fiscal year ending March 2025 being 45.8 billion yen and segment profit being 23.1 billion yen. The aim is to concentrate management resources in key areas and lead to sustainable growth. While there are voices evaluating it as contributing to improving the balance sheet, concerns about declining revenue levels are predominant.